 | • レポートコード：MRC309Z7143 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のヒトドラッグデリバリーシステムの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のヒトドラッグデリバリーシステム市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ヒトドラッグデリバリーシステムの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ヒトドラッグデリバリーシステム市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・手動型、自動型 用途別セグメント ・病院&診療所、小売薬局、その他 主要な市場プレーヤー ・BD、NoVo Engineering、Elcam Medical、Enable lnjections、Phillips-Medisize、stevanato、Ypsomed、Insulet Corporation、Tandem Diabetes Care、Medtronic plc、Hunan Ping An、Shanghai Kindly、Wanbangde、Wuxi Yushou、Guangdong Haiou 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヒトドラッグデリバリーシステム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒトドラッグデリバリーシステムメーカーの企業概要、2019年～2022年までのヒトドラッグデリバリーシステムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒトドラッグデリバリーシステムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ヒトドラッグデリバリーシステムの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのヒトドラッグデリバリーシステムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒトドラッグデリバリーシステム市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびヒトドラッグデリバリーシステムの産業チェーンを掲載しています。 ・第14、15章では、ヒトドラッグデリバリーシステムの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ヒトドラッグデリバリーシステムの概要 - 種類別分析（2018年vs2022年vs2029年）：手動型、自動型 - 用途別分析（2018年vs2022年vs2029年）：病院&診療所、小売薬局、その他 - 世界のヒトドラッグデリバリーシステム市場規模・予測 - 世界のヒトドラッグデリバリーシステム生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - BD、NoVo Engineering、Elcam Medical、Enable lnjections、Phillips-Medisize、stevanato、Ypsomed、Insulet Corporation、Tandem Diabetes Care、Medtronic plc、Hunan Ping An、Shanghai Kindly、Wanbangde、Wuxi Yushou、Guangdong Haiou ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：手動型、自動型 ・用途別分析2018年-2029年：病院&診療所、小売薬局、その他 ・ヒトドラッグデリバリーシステムの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ヒトドラッグデリバリーシステムのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ヒトドラッグデリバリーシステムのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ヒトドラッグデリバリーシステムの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ヒトドラッグデリバリーシステムの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Human Drug Delivery System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Human Drug Delivery System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Drug Delivery System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Drug Delivery System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Drug Delivery System market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, NoVo Engineering, Elcam Medical, Enable lnjections and Phillips-Medisize, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Manual
Automatic
Market segment by Application
Hospitals and Clinics
Retail Pharmacy
Others
Major players covered
BD
NoVo Engineering
Elcam Medical
Enable lnjections
Phillips-Medisize
stevanato
Ypsomed
Insulet Corporation
Tandem Diabetes Care
Medtronic plc
Hunan Ping An
Shanghai Kindly
Wanbangde
Wuxi Yushou
Guangdong Haiou
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Drug Delivery System, with price, sales, revenue and global market share of Human Drug Delivery System from 2018 to 2023.
Chapter 3, the Human Drug Delivery System competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Drug Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Drug Delivery System.
Chapter 14 and 15, to describe Human Drug Delivery System sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Human Drug Delivery System
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Drug Delivery System Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Manual
1.3.3 Automatic
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Drug Delivery System Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Human Drug Delivery System Market Size & Forecast
1.5.1 Global Human Drug Delivery System Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Drug Delivery System Sales Quantity (2018-2029)
1.5.3 Global Human Drug Delivery System Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Human Drug Delivery System Product and Services
2.1.4 BD Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BD Recent Developments/Updates
2.2 NoVo Engineering
2.2.1 NoVo Engineering Details
2.2.2 NoVo Engineering Major Business
2.2.3 NoVo Engineering Human Drug Delivery System Product and Services
2.2.4 NoVo Engineering Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 NoVo Engineering Recent Developments/Updates
2.3 Elcam Medical
2.3.1 Elcam Medical Details
2.3.2 Elcam Medical Major Business
2.3.3 Elcam Medical Human Drug Delivery System Product and Services
2.3.4 Elcam Medical Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Elcam Medical Recent Developments/Updates
2.4 Enable lnjections
2.4.1 Enable lnjections Details
2.4.2 Enable lnjections Major Business
2.4.3 Enable lnjections Human Drug Delivery System Product and Services
2.4.4 Enable lnjections Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Enable lnjections Recent Developments/Updates
2.5 Phillips-Medisize
2.5.1 Phillips-Medisize Details
2.5.2 Phillips-Medisize Major Business
2.5.3 Phillips-Medisize Human Drug Delivery System Product and Services
2.5.4 Phillips-Medisize Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Phillips-Medisize Recent Developments/Updates
2.6 stevanato
2.6.1 stevanato Details
2.6.2 stevanato Major Business
2.6.3 stevanato Human Drug Delivery System Product and Services
2.6.4 stevanato Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 stevanato Recent Developments/Updates
2.7 Ypsomed
2.7.1 Ypsomed Details
2.7.2 Ypsomed Major Business
2.7.3 Ypsomed Human Drug Delivery System Product and Services
2.7.4 Ypsomed Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ypsomed Recent Developments/Updates
2.8 Insulet Corporation
2.8.1 Insulet Corporation Details
2.8.2 Insulet Corporation Major Business
2.8.3 Insulet Corporation Human Drug Delivery System Product and Services
2.8.4 Insulet Corporation Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Insulet Corporation Recent Developments/Updates
2.9 Tandem Diabetes Care
2.9.1 Tandem Diabetes Care Details
2.9.2 Tandem Diabetes Care Major Business
2.9.3 Tandem Diabetes Care Human Drug Delivery System Product and Services
2.9.4 Tandem Diabetes Care Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Tandem Diabetes Care Recent Developments/Updates
2.10 Medtronic plc
2.10.1 Medtronic plc Details
2.10.2 Medtronic plc Major Business
2.10.3 Medtronic plc Human Drug Delivery System Product and Services
2.10.4 Medtronic plc Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Medtronic plc Recent Developments/Updates
2.11 Hunan Ping An
2.11.1 Hunan Ping An Details
2.11.2 Hunan Ping An Major Business
2.11.3 Hunan Ping An Human Drug Delivery System Product and Services
2.11.4 Hunan Ping An Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hunan Ping An Recent Developments/Updates
2.12 Shanghai Kindly
2.12.1 Shanghai Kindly Details
2.12.2 Shanghai Kindly Major Business
2.12.3 Shanghai Kindly Human Drug Delivery System Product and Services
2.12.4 Shanghai Kindly Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Kindly Recent Developments/Updates
2.13 Wanbangde
2.13.1 Wanbangde Details
2.13.2 Wanbangde Major Business
2.13.3 Wanbangde Human Drug Delivery System Product and Services
2.13.4 Wanbangde Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Wanbangde Recent Developments/Updates
2.14 Wuxi Yushou
2.14.1 Wuxi Yushou Details
2.14.2 Wuxi Yushou Major Business
2.14.3 Wuxi Yushou Human Drug Delivery System Product and Services
2.14.4 Wuxi Yushou Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Wuxi Yushou Recent Developments/Updates
2.15 Guangdong Haiou
2.15.1 Guangdong Haiou Details
2.15.2 Guangdong Haiou Major Business
2.15.3 Guangdong Haiou Human Drug Delivery System Product and Services
2.15.4 Guangdong Haiou Human Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Guangdong Haiou Recent Developments/Updates
3 Competitive Environment: Human Drug Delivery System by Manufacturer
3.1 Global Human Drug Delivery System Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Drug Delivery System Revenue by Manufacturer (2018-2023)
3.3 Global Human Drug Delivery System Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Drug Delivery System Manufacturer Market Share in 2022
3.4.2 Top 6 Human Drug Delivery System Manufacturer Market Share in 2022
3.5 Human Drug Delivery System Market: Overall Company Footprint Analysis
3.5.1 Human Drug Delivery System Market: Region Footprint
3.5.2 Human Drug Delivery System Market: Company Product Type Footprint
3.5.3 Human Drug Delivery System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Drug Delivery System Market Size by Region
4.1.1 Global Human Drug Delivery System Sales Quantity by Region (2018-2029)
4.1.2 Global Human Drug Delivery System Consumption Value by Region (2018-2029)
4.1.3 Global Human Drug Delivery System Average Price by Region (2018-2029)
4.2 North America Human Drug Delivery System Consumption Value (2018-2029)
4.3 Europe Human Drug Delivery System Consumption Value (2018-2029)
4.4 Asia-Pacific Human Drug Delivery System Consumption Value (2018-2029)
4.5 South America Human Drug Delivery System Consumption Value (2018-2029)
4.6 Middle East and Africa Human Drug Delivery System Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Drug Delivery System Sales Quantity by Type (2018-2029)
5.2 Global Human Drug Delivery System Consumption Value by Type (2018-2029)
5.3 Global Human Drug Delivery System Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Drug Delivery System Sales Quantity by Application (2018-2029)
6.2 Global Human Drug Delivery System Consumption Value by Application (2018-2029)
6.3 Global Human Drug Delivery System Average Price by Application (2018-2029)
7 North America
7.1 North America Human Drug Delivery System Sales Quantity by Type (2018-2029)
7.2 North America Human Drug Delivery System Sales Quantity by Application (2018-2029)
7.3 North America Human Drug Delivery System Market Size by Country
7.3.1 North America Human Drug Delivery System Sales Quantity by Country (2018-2029)
7.3.2 North America Human Drug Delivery System Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Drug Delivery System Sales Quantity by Type (2018-2029)
8.2 Europe Human Drug Delivery System Sales Quantity by Application (2018-2029)
8.3 Europe Human Drug Delivery System Market Size by Country
8.3.1 Europe Human Drug Delivery System Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Drug Delivery System Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Drug Delivery System Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Drug Delivery System Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Drug Delivery System Market Size by Region
9.3.1 Asia-Pacific Human Drug Delivery System Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Drug Delivery System Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Drug Delivery System Sales Quantity by Type (2018-2029)
10.2 South America Human Drug Delivery System Sales Quantity by Application (2018-2029)
10.3 South America Human Drug Delivery System Market Size by Country
10.3.1 South America Human Drug Delivery System Sales Quantity by Country (2018-2029)
10.3.2 South America Human Drug Delivery System Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Drug Delivery System Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Drug Delivery System Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Drug Delivery System Market Size by Country
11.3.1 Middle East & Africa Human Drug Delivery System Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Drug Delivery System Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Drug Delivery System Market Drivers
12.2 Human Drug Delivery System Market Restraints
12.3 Human Drug Delivery System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Drug Delivery System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Drug Delivery System
13.3 Human Drug Delivery System Production Process
13.4 Human Drug Delivery System Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Drug Delivery System Typical Distributors
14.3 Human Drug Delivery System Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer